PARP Inhibitors in the Treatment of Prostate Cancer: An Analysis of the Clinical Trial Landscape.

Cancer Med · 2025 · PMC12573472 · PMID 41165261

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

3.1 International Collaboration and Population Characteristics Clinical trials of the use of PARP inhibitors for the treatment of prostate cancer have demonstrated a significant trend toward international collaboration (Figure 2A ).

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.